FindTrial
Sign In

Treatment plan

OTHER7 trials

Sponsors

Department of Neurosurgery, Affiliated Hospital of Southwest Medical University, Donetsk National Medical University, Carolina Neurosurgery & Spine Associates, Fondazione Italiana Linfomi - ETS, NRG Oncology

Conditions

COVID-19Congenital Bone and Joint AbnormalitiesDiffuse Large B Cell LymphomaJoint DiseasesMyelopathyNeurogenic ClaudicationOrthopedic Surgery ComplicationsPancreas Cancer

Phase 1

Effects of wecht-based multistage integrated care on glioma patients and primary caregivers: a randomized controlled trial
RecruitingChiCTR2400085215
Department of Neurosurgery, Affiliated Hospital of Southwest Medical UniversitySymptoms of anxiety and depression in glioma patients
Start: 2024-06-04Updated: 2024-07-08

Phase 2

R-CHOP14 or R-CHOP21 &Consolidation PET-Oriented Radiotherapy (RT) in DLBCL Patients
CompletedNCT03364439
Fondazione Italiana Linfomi - ETSDiffuse Large B Cell Lymphoma
Start: 2012-01-31End: 2021-03-18Updated: 2022-03-03

Unknown Phase

Telemedicine Consultation in Trauma and Orthopedic
CompletedNCT00815243
Donetsk National Medical UniversityCongenital Bone and Joint Abnormalities, Joint Diseases, Orthopedic Surgery Complications +1
Start: 2007-09-30End: 2008-09-30Updated: 2008-12-29
This Study is to Determine if Degenerative Spinal Pain and Disorders Cause the Levels of Substance P to Change in a Patients Saliva, Blood and/or Cerebrospinal Fluid.
TerminatedNCT01458938
Carolina Neurosurgery & Spine AssociatesMyelopathy, Neurogenic Claudication, Spinal Disease +1
Start: 2009-07-31End: 2014-04-30Updated: 2017-02-01
Increasing the Dose of Survivorship Care Planning in Improving Care and Outcomes in Prostate Cancer Survivors Receiving Androgen Deprivation Therapy
CompletedNCT03860961
NRG OncologyProstate Adenocarcinoma
Start: 2019-07-26End: 2025-09-04Updated: 2025-11-03
COVID-19 Infection
NCT05926076
Tianjin First Central HospitalCOVID-19, Renal Transplant Infection
Start: 2023-07-25End: 2023-07-30Target: 610Updated: 2023-07-03
Molecular Profile-related Individualized Targeted Therapy in Resected Pancreatic Cancer With High-Risk of Cancer Recurrence
RecruitingNCT06228599
Medical College of WisconsinPancreas Cancer
Start: 2024-02-29End: 2026-07-31Target: 40Updated: 2025-04-27